About

About Countable Labs Countable Labs (formerly Enumerix) is redefining PCR with single-molecule precision and category-defining sensitivity, overcoming the limitations of other PCR and next-generation sequencing approaches. The company’s Countable PCR technology delivers at least 10 times the sensitivity and precision of other PCR technologies in a single reaction. Plus, Countable PCR’s single-molecule isolation enables 10-color multiplexing and simplifies assay development. Founded in 2019 by Stephen Fodor, Ari Chaney, and Christina Fan, Countable Labs is privately held and supported by leading life sciences tools investors including ARCH Venture Partners and F-Prime Capital. The company is headquartered in Palo Alto, Calif.